The Patent Finder

Supergen, Inc.

Also on record
Records under this name other than patents Supergen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Supergen, Inc.

PatentTitleStatus Expires Confidence
US 8,710,057Imidazo[1,2-b]pyridazine and Pyrazolo[1,5-a]pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,750,007Imidazo[1,2-beta]pyridazine and PYRAZOLO[1,5-Alpha]PYRIMIDINE Derivatives and Their Use as Protein Kinase Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,700,567Oligonucleotide Analogues Incorporating 5-AZA-CYTOSINE Therein
Formerly held
Term ended
Term ended Sep 29, 2025 · High confidence
Term endedTerm ended Sep 29, 2025High confidence
US 8,461,123Oligonucleotide Analogues Incorporating 5-AZA-CYTOSINE Therein
Formerly held
Lapsed on the fee record
Ended Jun 11, 2025 · High confidence
Lapsed on the fee recordEnded Jun 11, 2025High confidence
US 7,250,416Azacytosine Analogs and Derivatives
Formerly held
Term ended
Term ended Mar 11, 2025 · High confidence
Term endedTerm ended Mar 11, 2025High confidence
US 6,710,195Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
Formerly held
Term ended
Term ended Nov 26, 2022 · From the USPTO record
Term endedTerm ended Nov 26, 2022From the USPTO record
US 7,135,464Method of Administering Decitabine
Formerly held
Term ended
Term ended Jun 18, 2022 · Medium confidence
Term endedTerm ended Jun 18, 2022Medium confidence
US 7,144,873Kit for Delivering Decitabine in Vivo
Formerly held
Term ended
Term ended Jun 18, 2022 · Medium confidence
Term endedTerm ended Jun 18, 2022Medium confidence
US 8,552,018Substituted Tricyclic Compounds as Protein Kinase Inhibitors
Formerly held
Lapsed on the fee record
Ended Oct 8, 2021 · Medium confidence
Lapsed on the fee recordEnded Oct 8, 2021Medium confidence
US 8,445,502Pharmaceutical Formulations Comprising Salts of a Protein Kinase Inhibitor and Methods of Using Same
Formerly held
Lapsed on the fee record
Ended May 21, 2021 · High confidence
Lapsed on the fee recordEnded May 21, 2021High confidence
10 of 82 patents shown.
Pro members see all 82.
Pro members: see all 82 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited